Microba Life Sciences LimitedASX: MAP

Suspension from Quotation

· Issued by Microba Life Sciences Limited via ASX

Filed with ASX · · 2 pages · English

Summary by 6ix AI

Microba Life Sciences Limited has requested a voluntary suspension of its quoted securities, effective immediately, pending an announcement regarding a proposed merger. The suspension is due to concerns about the company's financial capacity to complete the merger and its cashflow position. Microba anticipates that trading in its securities could be materially prejudicial to its financial viability until further clarity is achieved.

Written by 6ix AI from the company’s filing. How 6ix writes summaries

Release

Market Announcement 17 November 2026 Microba Life Sciences Limited (ASX: MAP) – Suspension from Quotation The securities of Microba Life Sciences Limited (‘MAP’) will be suspended from quotation immediately under Listing Rule 17.2 at the request of MAP, pending the release of an announcement...

Microba Life Sciences Limited on 6ix

Story so far

Earlier from Microba Life Sciences

Later from Microba Life Sciences

All Microba Life Sciences news releases